Rosacea: New and Emerging Treatments

@article{Moustafa2014RosaceaNA,
  title={Rosacea: New and Emerging Treatments},
  author={Farah Moustafa and Laura F. Sandoval and Steven R. Feldman},
  journal={Drugs},
  year={2014},
  volume={74},
  pages={1457-1465}
}
Rosacea is a chronic inflammatory skin condition that negatively impacts patients’ quality of life. We sought to review important aspects of the pathogenesis of rosacea and the role of new treatment options in its management. New, emerging treatments show promise; however, quality randomized controlled trials for many of these drugs are lacking. Brimonidine tartrate is an effective newly approved treatment for erythematotelangiectatic rosacea. Topical oxymetazoline has potential for the… 

New developments in the treatment of rosacea – role of once-daily ivermectin cream

In comparing topical ivermectin and metronidazole, iverMectin was more effective; this treatment modality boasted more improved quality of life, reduced lesion counts, and more favorable participant and physician assessment of disease severity.

Treatment of rosacea with topical ivermectin cream: a series of 34 cases.

The use of topical ivermectin cream in the treatment of rosacea is evaluated in a series of 34 patients and the results are a reflection of the reality of clinical practice and the perception of patients of the treatment.

Case Report Treatment of rosacea with topical ivermectin cream: a series of 34 cases

The use of topical ivermectin cream in the treatment of rosacea is evaluated in a series of 34 patients and the results are a reflection of the reality of clinical practice and the perception of patients of the treatment.

Efficacy of Topical Timolol 0.5% in the Treatment of Acne and Rosacea: A Multicentric Study.

Topical timolol maleate 0.5% demonstrated effectiveness in the treatment of acne, especially in noninflammatory lesions, but seems to be more effective in erythematotelangiectatic rosacea than papulopustular rosace lesions, with insignificant side effects.

Combination of new multifunctional molecules for erythematotelangiectatic rosacea disorder

Although rosacea is a skin condition disorder that is difficult to heal, the studies have shown that this active ingredient could be a dermocosmetic support, especially for erythematotelangiectatic rosace armamentarium.

Ivermectin: A Review in Rosacea

  • E. Deeks
  • Medicine
    American Journal of Clinical Dermatology
  • 2015
Ivermectin 1 % cream is an effective and well tolerated option for the topical treatment of inflammatory lesions of rosacea, with the convenience of once-daily application.

Combination of new multifunctional molecules for erythematotelangiectatic rosacea disorder

Although rosacea is a skin condition disorder that is difficult to heal, the studies have shown that this active ingredient could be a dermocosmetic support, especially for erythematotelangiectatic rosace armamentarium.

Ivermectin in rosacea: a guide to its use in the EU

In patients with moderate to severe inflammatory lesions of papulopustular rosacea, treatment with ivermectin cream significantly improved treatment success rates, inflammatory lesion counts and health-related quality of life measures relative to the cream vehicle, and relative to metronidazole cream in short-term trials.

Treatment strategies, including antibiotics, to target the immune component of rosacea

This review will provide a brief overview of the pathophysiology of rosacea, as well as specific immunologic contributions to the disease state, including anti-parasitic, anti-inflammatory agents, and antibiotics.

Ivermectin cream for rosacea

  • Dtb Cmecpd
  • Medicine
    Drug and Therapeutics Bulletin
  • 2015
Ivermectin 10mg/g (1%) cream (Soolantra—Galderma) has received marketing authorisation for the treatment of inflammatory lesions of papulopustular rosacea in adults and the safety and effectiveness are reviewed.

References

SHOWING 1-10 OF 46 REFERENCES

Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.

The third article in this 5-part series reviews systemic therapies used to treat cutaneous rosacea based on consensus recommendations from the American Acne & Rosacea Society based on current understanding of research that describes pathophysiologic mechanisms that appear to be operative inrosacea.

Effective and evidence‐based management strategies for rosacea: summary of a Cochrane systematic review

There was some evidence to support the effectiveness of topical metronidazole, azelaic acid and doxycycline (40 mg) in the treatment of moderate to severe rosacea, and ciclosporin 0·05% ophthalmic emulsion for ocular rosace.

Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

  • J. D. Del Rosso
  • Medicine
    The Journal of clinical and aesthetic dermatology
  • 2012
An overview of cutaneous vasculature, role of alpha-adrenoreceptors, and a discussion of available medical therapies and treatment selection are presented, including emerging topical options for diffuse and persistent facial erythema of rosacea.

Advances in Understanding and Managing Rosacea: Part 2: The Central Role, Evaluation, and Medical Management of Diffuse and Persistent Facial Erythema of Rosacea

An overview of cutaneous vasculature, role of alpha-adrenoreceptors, and a discussion of available medical therapies and treatment selection are presented, including emerging topical options for diffuse and persistent facial erythema of rosacea.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.

Topical agents used in the treatment of the common clinical presentations of rosacea, including those that have been approved by the US Food and Drug Administration as well as alternative agents, are reviewed.

New insights into rosacea pathophysiology: a review of recent findings.

Use of oral isotretinoin in the management of rosacea.

The authors discuss the use of oral isotretinoin in the management of rosacea, exploring dosage, comparable efficacy, safety, and cost.

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

Ivermectin 1% cream was effective and safe in treating inflammatory lesions of papulopustular rosacea and significantly more subjects receiving IVM 1% reported having an "excellent" or "good" improvement, along with an improved QoL.

The molecular pathology of rosacea.